6 of 8
YANG
NMR spectra were performed in CDCl3 with
tetramethylsilane as an internal standard and recorded
ppm): 9.43 (d, J = 9.0 Hz, 1H, CH‐quinoline), 8.18 (d,
J = 8.5 Hz, 1H, CH‐quinoline), 7.97 (d, J = 8.5 Hz, 1H,
CH‐quinoline), 7.65 (d, J = 8.0 Hz, 1H, CH‐quinoline),
7.59 (t, J = 8.0 Hz, 1H, CH‐quinoline), 7.45 (t,
J = 7.5 Hz, 1H, CH‐quinoline), 7.37 (t, J = 7.5 Hz, 2H,
p‐CH‐aniline), 7.28 (d, J = 8.0 Hz, 4H, m‐CH‐aniline),
4.16 (s, 2H, NCH2CH2N), 4.14 (s, 2H, NCH2CH2N), 3.58
(sept, J = 6.5 Hz, 2H, CH(CH3)2), 3.52 (sept, J = 6.5 Hz,
2H, CH(CH3)2), 1.56 (d, J = 6.5 Hz, 6H, CH(CH3)2), 1.53
(d, J = 6.5 Hz, 6H, CH(CH3)2), 1.32–1.28 (m, 12H,
CH(CH3)2). 13C NMR (CDCl3, 125 MHz, δ, ppm): 182.5
(Ccarbene),173.0 (Ccarboxylate), 153.0, 147.8, 147.6, 146.8,
139.8, 134.5, 130.7, 130.3, 129.5, 128.8, 128.3, 127.3,
124.5, 122.3, 53.6 (NCH2CH2N), 28.7 (CH(CH3)2), 26.7
(CH(CH3)2), 26.6 (CH(CH3)2), 24.2 (CH(CH3)2), 23.7
(CH(CH3)2). FT‐IR (KBr, cm−1): 3072, 2962, 1659, 1618,
1597, 1562, 1489, 1460, 1425, 1329, 1303, 1272, 1174,
1151, 1107, 1049, 898, 803. HR‐MS (ESI): calcd for
C37H45ClN3O2Pd [M + H+]+ 704.2235; found 704.2241.
Anal. Calcd for [(SIPr)PdCl(quinoline‐2‐carboxylate)]
(C37H44ClN3O2Pd) (%): C, 63.07; H, 6.29; N, 5.96. Found
(%): C, 63.35; H, 6.47; N, 6.22.
1
at 400 MHz (for H NMR) and 100 MHz (for 13C NMR)
with a Bruker Avance 400 NMR spectrometer. High‐reso-
lution mass spectra were recorded with an Agilent 6550
iFunnel Q‐TOF MS system. FT‐IR spectra were recorded
with a Bruker IFS 120HR spectrometer using KBr discs.
The C, H and N analyses were performed with a Vario
El III Elementar. Column chromatography was carried
out using 230–400 mesh silica gel.
4.2 | General Procedure for Preparation of
(NHC)PdCl(N‐heterocyclic carboxylate)
Complexes
A sealable reaction tube equipped with a magnetic stir
bar was charged with imidazolium salt (0.6 mmol), PdCl2
(0.5 mmol), K2CO3 (1.5 mmol), (iso)quinoline carboxylic
acid (0.6 mmol) and anhydrous THF (5.0 ml). The mix-
ture was stirred under reflux for 12 h and then cooled
to room temperature and condensed under vacuum. The
residue was purified by flash chromatography on short
silica gel and recrystallized from n‐hexane–CH2Cl2 to
afford the desired products.
4.2.3 | [(IPr)PdCl(isoquinoline‐1‐carboxyl-
ate)] (2a)
4.2.1 | [(IPr)PdCl(quinoline‐2‐carboxyl-
ate)] (1a)
The procedure yielded 240 mg (68%) of the pure product
2a as a yellow powder. H NMR (CDCl3, 500 MHz, δ,
1
The procedure yielded 260 mg (74%) of the pure product
1a as a yellow powder. H NMR (CDCl3, 500 MHz, δ,
ppm): 9.83 (d, J = 8.5 Hz, 1H, CH‐isoquinoline), 8.59 (d,
J = 6.5 Hz, 1H, CH‐isoquinoline), 7.72–7.66 (m, 2H),
7.63–7.60 (m, 2H), 7.47 (t, J = 8.0 Hz, 2H, p‐CH‐aniline),
7.34 (d, J = 8.0 Hz, 4H, m‐CH‐aniline), 7.20 (s, 2H,
NCH═CHN), 3.01 (sept, J = 6.5 Hz, 4H, CH(CH3)2),
1.47 (d, J = 6.5 Hz, 12H, CH(CH3)2), 1.16 (d, J = 6.5 Hz,
12H, CH(CH3)2). 13C NMR (CDCl3, 125 MHz, δ, ppm):
173.3 (Ccarboxylate), 158.1 (Ccarbene), 148.9, 146.7, 138.3,
137.7, 134.5, 131.8, 130.3, 129.1, 127.9, 127.4, 126.5,
125.0, 124.7, 124.0, 28.6 (CH(CH3)2), 26.2 (CH(CH3)2),
22.9 (CH(CH3)2). FT‐IR (KBr, cm−1): 2963, 2927, 2868,
1657, 1621, 1591, 1501, 1467, 1414, 1383, 1353, 1332,
1291, 1210, 1153, 802. HR‐MS (ESI): calcd for
C37H43ClN3O2Pd [M + H+]+ 702.2079; found 702.2087.
Anal. Calcd for [(IPr)PdCl(isoquinoline‐1‐carboxylate)]
(C37H42ClN3O2Pd) (%): C, 63.25; H, 6.03; N, 5.98. Found
(%): C, 63.55; H, 6.31; N, 6.25.
1
ppm): 9.43 (d, J = 9.0 Hz, 1H, CH‐quinoline), 8.21 (d,
J = 8.0 Hz, 1H, CH‐quinoline), 7.99 (d, J = 8.0 Hz, 1H,
CH‐quinoline), 7.67 (d, J = 8.0 Hz, 1H, CH‐quinoline),
7.60 (t, J = 8.0 Hz, 1H, CH‐quinoline), 7.49–7.45 (m,
3H), 7.34 (d, J = 8.0 Hz, 4H, m‐CH‐aniline), 7.19 (s, 2H,
NCH═CHN), 3.07 (sept, J = 6.5 Hz, 4H, CH(CH3)2),
1.47 (d, J = 6.5 Hz, 12H, CH(CH3)2), 1.16 (d, J = 5.0 Hz,
12H, CH(CH3)2). 13C NMR (CDCl3, 125 MHz, δ, ppm):
173.1 (Ccarboxylate), 153.1 (Ccarbene), 151.4, 146.8, 139.8,
134.4, 130.7, 130.4, 128.9, 128.3, 127.4, 125.1, 124.1,
122.4, 28.7 (CH(CH3)2), 26.3 (CH(CH3)2). FT‐IR (KBr,
cm−1): 2965, 1659, 1618, 1562, 1514, 1462, 1413, 1383,
1365, 1349, 1269, 1209, 1174, 1152, 1107, 802. HR‐MS
(ESI): calcd for C37H43ClN3O2Pd [M + H+]+ 702.2079;
found 702.2083. Anal. Calcd for [(IPr)PdCl(quinoline‐2‐
carboxylate)] (C37H42ClN3O2Pd) (%): C, 63.25; H, 6.03;
N, 5.98. Found (%): C, 63.54; H, 6.15; N, 6.27.
4.2.4 | [(SIPr)PdCl(isoquinoline‐1‐carbox-
ylate)] (2b)
4.2.2 | [(SIPr)PdCl(quinoline‐2‐carboxyl-
ate)] (1b)
The procedure yielded 255 mg (72%) of the pure product
2b as a yellow powder. H NMR (CDCl3, 500 MHz, δ,
1
The procedure yielded 270 mg (77%) of the pure product
1b as a yellow powder. H NMR (CDCl3, 500 MHz, δ,
ppm): 9.81 (d, J = 8.5 Hz, 1H, CH‐isoquinoline), 8.56 (d,
J = 6.5 Hz, 1H, CH‐isoquinoline), 7.70–7.64 (m, 2H,
1